Accessibility Statement

News/Publications

View More

Know What's Trending

Publication Sign Up

View More

News (54)

Press Releases

Steptoe Earns "Highly Recommended" Recognition in World IP Review's USA Patent Rankings 2025

February 18, 2026

Media Mentions

Yi Han Dulkeith's Move to Steptoe Featured in Legal Media

October 7, 2025

Press Releases

Yi Han Dulkeith Joins Steptoe, Strengthens Life Sciences Patent Bench in New York

September 17, 2025

Press Releases

Steptoe Earns Top Recognition in 2025 China Business Law Awards

July 25, 2025

Publications (21)

Publications

Nintendo Patent's Surprise Review Signals a US Priority Shift

Bloomberg Law

December 12, 2025

By: Christopher A. Suarez, Katherine D. Cappaert, Anthony Pericolo

Publications

Adapting To A Plaintiff-Side Mindset For Patent Monetization

Law360

December 9, 2025

By: Katherine Tellez

Publications

A Comprehensive Overview of PTAB Trends for Biologics

June 26, 2023

By: Michael I. Green, Lawrence Kass, John J. Molenda, Ph.D.

Client Alerts

Industry Impact: Supreme Court Equates Broad Repatha® Antibody Patents to a "Hunting License" in Amgen v. Sanofi

May 26, 2023

By: Joseph F. Ecker, Z. Ying Li, Ph.D., Vishal C. Gupta

Blog Posts (4)

Step Into IP Blog

Federal Circuit Holds Gene Therapy Claims Patent Eligible in REGENXBIO v. Sarepta

March 26, 2026

By: Michael I. Green

Step Into IP Blog

USPTO Director Bars Foreign State-Owned Companies from Filing IPR Petitions in Precedential Ruling

March 23, 2026

By: Matthew O’Boyle

Step Into IP Blog

Can prior art reach back in time? SCOTUS denies Lynk Labs Inc.’s petition related to effective prior art date of a patent application in IPR proceedings

March 19, 2026

By: Scott Chappell, Jacob T. Michalakes

Step Into IP Blog

Director Squires Issues Memorandum on Additional Factors to Consider When Determining Whether to Institute Inter Partes Review or Post Grant Review

March 12, 2026

By: Colby Richardson

Filter your results